Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > Special Meeting. Oct. 31st
View:
Post by Ingiboy on Sep 23, 2022 12:39pm

Special Meeting. Oct. 31st

Any speculation as to the reason for this special meeting ?  Interesting that whatever the reason that it could not be done at an AGM.
Also interesting that the date is after the end of the 1 year Arbitration (assuming it ends on Oct. 18th).

Is it a shareholder information meeting: 
 * Announcing the Arbitrators findings.
* Possibly some deal has been struck with Shiseido
* The company is being sold
* Private Placement disclosure (who's buying and what impact that has on the ownership of shares)
* Dermal Injector is being submitted to the FDA for Approval
* New partnerships in Japan
* Yofoto launches RCS-01 and RCT-01 Trials

Wouldn't it be nice to get all of the above information but sadly it most likely will be none of the above.
Comment by Year3000 on Sep 24, 2022 1:09pm
What other reasons could there be? Could it be bad news? If so what?
Comment by RPINVESTOR on Sep 27, 2022 8:38am
Year3000:- I am starting to believe that this registering of the Special Meeting was done without any significant news behind it. LB CEO may just have decided that it is good to have something in place if there is a development initiated by Shiseido (ie. offer to purchase). This would then allow a vote on October 31 and a sale before the calendar (and tax year). I wouldn't be surprised if ...more  
Comment by BellEnd on Sep 27, 2022 11:38am
This post has been removed in accordance with Community Policy
Comment by Ingiboy on Sep 27, 2022 12:01pm
Yes, they must give us all of the pertinent information  regarding the meeting and as mentioned in my last post: "The directors must notify voting shareholders of the time and place of a shareholders' meeting. They must do so no more than 60 days and no fewer than 21 days before the meeting date." So that means the latest they can give us this information is Oct. 10th.
Comment by Ingiboy on Sep 27, 2022 12:09pm
Why would they cancel it ?   Will this be a zoom meeting for all shareholders to participate in ? I think there will be one main resolution to be voted on but I imagine there will be plenty of questions that they will be forced to answer.  I am beginning to think as the large shareholders add to their share count  through this latest Private Placement (I.E. Andrew Schutte, Jamie ...more  
Comment by MetzGER on Sep 27, 2022 12:35pm
Ingiboy i agree : After all this suffering and pain a share Price under 2$ would be a Desaster. I wouldnt sell No matter what will be
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities